Evidence map›Paper›PMID 37265694›Full record

ArticleFrontiers in endocrinology2023

Analysis of characteristics of four patients with adrenal unicentric Castleman disease.

Hao Yu, Yuepeng Wang, Yijun Li, Jin Du, Qinghua Guo, Weijun Gu, Zhaohui Lyu, Jingtao Dou, Yiming Mu, Li Zang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hao YuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yuepeng WangDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yijun LiDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Jin DuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Qinghua GuoDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Weijun GuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhaohui LyuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Jingtao DouDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yiming MuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Li ZangDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Chinese PLA General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Castleman Disease (CD) is a group of diseases with characteristic lymph node histopathology, characterized by marked enlargement of deep or superficial lymph nodes. Adrenal CD is rarely reported, and an accurate preoperative diagnosis of adrenal CD is difficult. Method: We report four cases of CD in the adrenal gland confirmed by pathology and review the characteristics of this rare disease, highlighting the necessity of diagnostic evaluation and follow-up of the patients. Results: All of the patients sought medical advice because of adrenal incidentalomas. No significant abnormalities were presented in the biochemistry or endocrine systems. The imaging suggested a moderate-to-large mass with uneven moderate contrast enhancement of the adrenal region, similar to a pheochromocytoma. All cases were misdiagnosed as pheochromocytomas before operation and finally confirmed by histopathology. Three cases were pathologically diagnosed as hyaline vascular CD, and one case was diagnosed as plasma cell CD. All the patients are alive without recurrence after a median follow-up of 8 years. Conclusion: The adrenal CD should be considered after excluding pheochromocytoma and malignancy in the adrenal region. The long-term prognosis of patients with complete resection of the mass is excellent.

Indexed as

Adrenal Gland NeoplasmsCastleman DiseasePheochromocytomaHumansLymph NodesPrognosisadrenal glandadrenal incidentalomacastleman diseaselymphomapheochromocytoma

Identifiers

PMID37265694
PMCPMC10230092
OpenAlexW4376875659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.